Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|September 12, 2023
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3Maryam Oroujeni, Ekaterina A Bezverkhniaia, Tianqi Xu, et al.
Theranostics|September 29, 2023
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancerOlga Bragina, Vladimir Chernov, Mariia Larkina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2025
Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle StudyMaryam Oroujeni, Kristina Westerlund, Eleftherios Papalanis, et al.
International Journal of Biological Macromolecules|March 16, 2026
Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' orderEleftherios Papalanis, Ruonan Li, Maryam Oroujeni, et al.
Biomaterials|October 29, 2020
Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of PrincipleJavad Garousi, Emma von Witting, Jesper Borin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2024
Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profileYongsheng Liu, Maryam Oroujeni, Yunqi Liao, et al.
International Journal of Molecular Sciences|April 27, 2024
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) FusionSergey M Deyev, Maryam Oroujeni, Javad Garousi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2018
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of PrincipleKristina Westerlund, Mohamed Altai, Bogdan Mitran, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 29, 2023
Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivityCharles Dahlsson Leitao, Anna Mestre Borras, Tianqi Xu, et al.
International Journal of Molecular Sciences|June 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular ArchitectureVladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly, et al.
Pageof 5